These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24353149)

  • 1. Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop-the-losers trials.
    Bowden J; Glimm E
    Biom J; 2014 Mar; 56(2):332-49. PubMed ID: 24353149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditionally unbiased estimation in the normal setting with unknown variances.
    Robertson DS; Glimm E
    Commun Stat Theory Methods; 2019; 48(3):616-627. PubMed ID: 31217751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the selected treatment mean in two stage drop-the-losers design.
    Masihuddin ; Misra N
    J Biopharm Stat; 2024 Mar; 34(2):164-189. PubMed ID: 36872467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical Bayes estimation of the selected treatment mean for two-stage drop-the-loser trials: a meta-analytic approach.
    Bowden J; Brannath W; Glimm E
    Stat Med; 2014 Feb; 33(3):388-400. PubMed ID: 23873666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point estimation following a two-stage group sequential trial.
    Grayling MJ; Wason JM
    Stat Methods Med Res; 2023 Feb; 32(2):287-304. PubMed ID: 36384365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusting for treatment selection in phase II/III clinical trials with time to event data.
    Khan JN; Kimani PK; Glimm E; Stallard N
    Stat Med; 2023 Jan; 42(2):146-163. PubMed ID: 36419206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shrinkage estimation in two-stage adaptive designs with midtrial treatment selection.
    Carreras M; Brannath W
    Stat Med; 2013 May; 32(10):1677-90. PubMed ID: 22744936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interval estimation in two-stage, drop-the-losers clinical trials with flexible treatment selection.
    Neal D; Casella G; Yang MC; Wu SS
    Stat Med; 2011 Oct; 30(23):2804-14. PubMed ID: 21823142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accounting for selection and correlation in the analysis of two-stage genome-wide association studies.
    Robertson DS; Prevost AT; Bowden J
    Biostatistics; 2016 Oct; 17(4):634-49. PubMed ID: 26993061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point estimation in adaptive enrichment designs.
    Kunzmann K; Benner L; Kieser M
    Stat Med; 2017 Nov; 36(25):3935-3947. PubMed ID: 28783881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.
    Robertson DS; Prevost AT; Bowden J
    Stat Med; 2016 Sep; 35(22):3907-22. PubMed ID: 27103068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation after subpopulation selection in adaptive seamless trials.
    Kimani PK; Todd S; Stallard N
    Stat Med; 2015 Aug; 34(18):2581-601. PubMed ID: 25903293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point estimation following two-stage adaptive threshold enrichment clinical trials.
    Kimani PK; Todd S; Renfro LA; Stallard N
    Stat Med; 2018 Sep; 37(22):3179-3196. PubMed ID: 29855066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbiased estimation of selected treatment means in two-stage trials.
    Bowden J; Glimm E
    Biom J; 2008 Aug; 50(4):515-27. PubMed ID: 18663760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of estimation methods adjusting for selection bias in adaptive enrichment designs with time-to-event endpoints.
    Di Stefano F; Pannaux M; Correges A; Galtier S; Robert V; Saint-Hilary G
    Stat Med; 2022 May; 41(10):1767-1779. PubMed ID: 35098579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated early.
    Shimura M; Maruo K; Gosho M
    Pharm Stat; 2018 Sep; 17(5):400-413. PubMed ID: 29687592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interval estimation in multi-stage drop-the-losers designs.
    Lu X; He Y; Wu SS
    Stat Methods Med Res; 2018 Jan; 27(1):221-233. PubMed ID: 26980742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-stage drop-the-losers design for multi-arm clinical trials.
    Wason J; Stallard N; Bowden J; Jennison C
    Stat Methods Med Res; 2017 Feb; 26(1):508-524. PubMed ID: 25228636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.